Ulf WIInberg - Dec 1, 2022 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
Director
Signature
By: /s/ Christine Klaskin, Attorney-in-Fact
Stock symbol
INKT
Transactions as of
Dec 1, 2022
Transactions value $
$14,000
Form type
4
Date filed
12/5/2022, 05:27 PM
Previous filing
Oct 5, 2022
Next filing
Jan 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INKT Common Stock Award $14K +5.36K +17.48% $2.61 36.1K Dec 1, 2022 Direct F1, F2
holding INKT Common Stock 278K Dec 1, 2022 See Footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.
F2 Includes shares inadvertently excluded from a Form 4 filed on September 19, 2022.
F3 Shares are held in an irrevocable trust for the benefit of Mr. Wiinberg's family. The indirectly owned shares were inadvertently excluded from a Form 4 filed on September 19, 2022.